口服三氧化二砷治疗复发的急性早幼粒细胞白血病。 - Suppr

Suppr

超能文献

Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia.

作者信息

Au Wing-Yan, Kumana Cyrus R, Kou Maybelle, Mak Raymond, Chan Godfrey C F, Lam Ching-Wan, Kwong Yok-Lam

出版信息

Blood. 2003 Jul 1;102(1):407-8. doi: 10.1182/blood-2003-01-0298.

DOI:10.1182/blood-2003-01-0298

PMID:12814916

Abstract

摘要

相似文献

Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia.口服三氧化二砷治疗复发的急性早幼粒细胞白血病。

Blood. 2003 Jul 1;102(1):407-8. doi: 10.1182/blood-2003-01-0298.

Efficacy of prolonged therapy with combined arsenic trioxide and ATRA for relapse of acute promyelocytic leukemia.三氧化二砷联合全反式维甲酸长期治疗急性早幼粒细胞白血病复发的疗效

Haematologica. 2011 Sep;96(9):1390-1. doi: 10.3324/haematol.2011.045500. Epub 2011 Jun 9.

Arsenic trioxide combination improves survival in APL.三氧化二砷联合用药可提高急性早幼粒细胞白血病患者的生存率。

Lancet Oncol. 2013 Aug;14(9):e346. doi: 10.1016/s1470-2045(13)70348-6.

Int J Hematol. 2002 Jan;75(1):104-6. doi: 10.1007/BF02981989.

Arsenic trioxide for the treatment of a relapsed acute promyelocytic leukemia with acute renal failure.

Pediatr Blood Cancer. 2011 Dec 1;57(6):1085. doi: 10.1002/pbc.23230. Epub 2011 Jun 8.

Long-term remission in a case of acute promyelocytic leukemia patient with marked myelofibrosis treated with arsenic trioxide, all-trans retinoic acid and consolidation therapy with daunorubicin plus cytarabine.一名急性早幼粒细胞白血病患者，伴有明显骨髓纤维化，经三氧化二砷、全反式维甲酸治疗，并采用柔红霉素加阿糖胞苷进行巩固治疗后实现长期缓解。

Leuk Res. 2012 Jun;36(6):e119-21. doi: 10.1016/j.leukres.2012.02.004. Epub 2012 Mar 2.

Combination brings long-term remission in acute promyelocytic leukemia refractory for both all-trans retinoic acid and arsenic trioxide.联合治疗使对全反式维甲酸和三氧化二砷均耐药的急性早幼粒细胞白血病实现长期缓解。

Eur J Haematol. 2008 Aug;81(2):160. doi: 10.1111/j.1600-0609.2008.01079.x. Epub 2008 Mar 19.

Successful post-remission therapy with a combination of all-trans retinoic acid and arsenic trioxide in an elderly Japanese patient newly diagnosed with acute promyelocytic leukemia.全反式维甲酸与三氧化二砷联合用于一名新诊断的老年日本急性早幼粒细胞白血病患者的缓解后治疗取得成功。

Int J Hematol. 2010 Jan;91(1):152-3. doi: 10.1007/s12185-009-0470-7. Epub 2009 Dec 25.

Combined arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia recurring from previous relapses successfully treated using arsenic trioxide.三氧化二砷联合全反式维甲酸治疗既往曾用三氧化二砷成功治疗后复发的急性早幼粒细胞白血病。

Br J Haematol. 2002 Apr;117(1):130-2. doi: 10.1046/j.1365-2141.2002.03409.x.

Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial.口服四砷四硫化物配方与静脉注射三氧化二砷作为急性早幼粒细胞白血病一线治疗的比较：一项多中心随机对照试验。

J Clin Oncol. 2013 Nov 20;31(33):4215-21. doi: 10.1200/JCO.2013.48.8312. Epub 2013 Oct 14.

引用本文的文献

ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL.ALLG APML5：急性早幼粒细胞白血病巩固治疗期间口服三氧化二砷的生物利用度和安全性。

Blood Adv. 2025 Mar 25;9(6):1476-1484. doi: 10.1182/bloodadvances.2024015397.

Arsenic trioxide: applications, mechanisms of action, toxicity and rescue strategies to date.三氧化二砷：应用、作用机制、毒性及迄今的抢救策略。

Arch Pharm Res. 2024 Mar;47(3):249-271. doi: 10.1007/s12272-023-01481-y. Epub 2023 Dec 26.

Hematopoietic Stem Cell Transplantation in Acute Promyelocytic Leukemia in the Era of All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (ATO).全反式维甲酸（ATRA）和三氧化二砷（ATO）时代急性早幼粒细胞白血病的造血干细胞移植

Cancers (Basel). 2023 Aug 15;15(16):4111. doi: 10.3390/cancers15164111.

An overview of arsenic trioxide-involved combined treatment algorithms for leukemia: basic concepts and clinical implications.三氧化二砷治疗白血病联合治疗方案概述：基本概念与临床意义

Cell Death Discov. 2023 Jul 27;9(1):266. doi: 10.1038/s41420-023-01558-z.

Editorial: Acute promyelocytic leukemia - towards a chemotherapy-free approach to cure in all patients, Volume II.社论：急性早幼粒细胞白血病——迈向所有患者无需化疗即可治愈的方法，第二卷

Front Oncol. 2023 Jun 27;13:1238486. doi: 10.3389/fonc.2023.1238486. eCollection 2023.

Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021.急性早幼粒细胞白血病：1991 年至 2021 年基于人群的 ATRA 和口服 ATO 治疗的流行病学和结局研究。

BMC Cancer. 2023 Feb 10;23(1):141. doi: 10.1186/s12885-023-10612-z.

The treatment of acute promyelocytic leukemia in 2023: Paradigm, advances, and future directions.2023年急性早幼粒细胞白血病的治疗：模式、进展与未来方向。

Front Oncol. 2023 Jan 18;12:1062524. doi: 10.3389/fonc.2022.1062524. eCollection 2022.

Characteristics and predictors of early hospital deaths in newly diagnosed APL: a 13-year population-wide study.新诊断 APL 患者早期院内死亡的特征和预测因素：一项为期 13 年的全人群研究。

Blood Adv. 2021 Jul 27;5(14):2829-2838. doi: 10.1182/bloodadvances.2021004789.

Acute promyelocytic leukemia current treatment algorithms.急性早幼粒细胞白血病现行治疗方案。

Blood Cancer J. 2021 Jun 30;11(6):123. doi: 10.1038/s41408-021-00514-3.

Acute Promyelocytic Leukemia: A History over 60 Years-From the Most Malignant to the most Curable Form of Acute Leukemia.急性早幼粒细胞白血病：60 多年的历程——从最恶性的急性白血病形式到最可治愈的形式

Oncol Ther. 2019 Jun;7(1):33-65. doi: 10.1007/s40487-018-0091-5. Epub 2019 Feb 5.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验